Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Wahl Bryan. Insider active across 1 company, notably Tarsus Pharmaceuticals, Inc.. Aggregated, 11 disclosures have been recorded. Breakdown: 0 buy · 5 sells. Total volume traded: €415k. History available since 29 November 2022. The latest transaction was disclosed on 17 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Bryan Wahl is a declarant linked to Tarsus Pharmaceuticals, Inc. (XNAS), where he is General Counsel. He has 11 filings in total, and in the recent filings observed between 2022-12-01 and 2026-03-19, the transactions are sales totaling EUR 415151, with Levée d'options as the most common transaction nature.